Skip to main content
Top
Published in: European Journal of Clinical Microbiology & Infectious Diseases 2/2013

01-02-2013 | Article

Activity of ethanol and daptomycin lock on biofilm generated by an in vitro dynamic model using real subcutaneous injection ports

Authors: C. Aumeran, P. Guyot, M. Boisnoir, C. Robin-Hennequin, M. Vidal, C. Forestier, O. Traore, O. Lesens, Clermont-Ferrand Biofilm Study Group

Published in: European Journal of Clinical Microbiology & Infectious Diseases | Issue 2/2013

Login to get access

Abstract

Vancomycin lock solution (LS) is recommended for the conservative treatment of subcutaneous injection port (SIP)-related infections, but may be associated with failure. We used an in vitro dynamic model of biofilm formation in an SIP, based on a continuous flow circulating via a real SIP, to assess the effectiveness of vancomycin (5 mg/ml), daptomycin (5 mg/ml) and ethanol 40 % LS in eradicating a pre-established Staphylococcus epidermidis biofilm. Heparin, Ringer’s lactate and enoxaparin sodium LS were used as controls. The logarithmic reductions of colony-forming units (CFU) were compared by Student’s t-test. After 24 h of exposure, the vancomycin LS did not exert a greater bactericidal effect than the heparin LS control (mean logarithmic reduction: 2.27 ± 0.58 vs. 1.34 ± 0.22, respectively, p = 0.3). The mean logarithmic reduction was greater with daptomycin LS (5.45 ± 0.14 vs. 0.39 ± 0.12, p < 0.01) and ethanol LS (6.79 ± 1.03 vs. 1.43 ± 0.54, p = 0.02). Bacterial revival after exposure to 24 h of LS was assessed. The mean viable bacteria count was significantly higher for vancomycin LS (9.36 ± 0.10 log10CFU) and daptomycin LS (9.16 ± 0.02 log10CFU) than for ethanol LS (2.95 ± 1.65 log10CFU). Ethanol appeared to be the most attractive option to treat SIP-related infection, but its poor ability to entirely disrupt the biofilm structure may require its use in association with a dispersal agent to avoid renewal of the biofilm.
Literature
1.
go back to reference Walser EM (2012) Venous access ports: indications, implantation technique, follow-up, and complications. Cardiovasc Intervent Radiol 35:751–764PubMedCrossRef Walser EM (2012) Venous access ports: indications, implantation technique, follow-up, and complications. Cardiovasc Intervent Radiol 35:751–764PubMedCrossRef
2.
go back to reference Maki DG, Kluger DM, Crnich CJ (2006) The risk of bloodstream infection in adults with different intravascular devices: a systematic review of 200 published prospective studies. Mayo Clin Proc 81:1159–1171PubMedCrossRef Maki DG, Kluger DM, Crnich CJ (2006) The risk of bloodstream infection in adults with different intravascular devices: a systematic review of 200 published prospective studies. Mayo Clin Proc 81:1159–1171PubMedCrossRef
3.
go back to reference Crisinel M, Mahy S, Ortega-Debalon P, Buisson M, Favre JP, Chavanet P, Piroth L (2009) Incidence, prévalence et facteurs de risque de survenue d’une première complication infectieuse sur chambres à cathéter implantables. Méd Mal Infect 39:252–258PubMedCrossRef Crisinel M, Mahy S, Ortega-Debalon P, Buisson M, Favre JP, Chavanet P, Piroth L (2009) Incidence, prévalence et facteurs de risque de survenue d’une première complication infectieuse sur chambres à cathéter implantables. Méd Mal Infect 39:252–258PubMedCrossRef
4.
go back to reference Opilla M (2008) Epidemiology of bloodstream infection associated with parenteral nutrition. Am J Infect Control 36:S173.e5–S173.e8CrossRef Opilla M (2008) Epidemiology of bloodstream infection associated with parenteral nutrition. Am J Infect Control 36:S173.e5–S173.e8CrossRef
5.
go back to reference Simon A, Ammann RA, Bode U, Fleischhack G, Wenchel HM, Schwamborn D, Gravou C, Schlegel PG, Rutkowski S, Dannenberg C, Körholz D, Laws HJ, Kramer MH (2008) Healthcare-associated infections in pediatric cancer patients: results of a prospective surveillance study from university hospitals in Germany and Switzerland. BMC Infect Dis 8:70PubMedCrossRef Simon A, Ammann RA, Bode U, Fleischhack G, Wenchel HM, Schwamborn D, Gravou C, Schlegel PG, Rutkowski S, Dannenberg C, Körholz D, Laws HJ, Kramer MH (2008) Healthcare-associated infections in pediatric cancer patients: results of a prospective surveillance study from university hospitals in Germany and Switzerland. BMC Infect Dis 8:70PubMedCrossRef
6.
go back to reference Adler A, Yaniv I, Solter E, Freud E, Samra Z, Stein J, Fisher S, Levy I (2006) Catheter-associated bloodstream infections in pediatric hematology–oncology patients: factors associated with catheter removal and recurrence. J Pediatr Hematol Oncol 28:23–28PubMed Adler A, Yaniv I, Solter E, Freud E, Samra Z, Stein J, Fisher S, Levy I (2006) Catheter-associated bloodstream infections in pediatric hematology–oncology patients: factors associated with catheter removal and recurrence. J Pediatr Hematol Oncol 28:23–28PubMed
7.
go back to reference Chang YF, Lo AC, Tsai CH, Lee PY, Sun S, Chang TH, Chen CC, Chang YS, Chen JR (2011) Higher complication risk of totally implantable venous access port systems in patients with advanced cancer—a single institution retrospective analysis. Palliat Med (in press) Chang YF, Lo AC, Tsai CH, Lee PY, Sun S, Chang TH, Chen CC, Chang YS, Chen JR (2011) Higher complication risk of totally implantable venous access port systems in patients with advanced cancer—a single institution retrospective analysis. Palliat Med (in press)
8.
go back to reference Flynn PM, Willis B, Gaur AH, Shenep JL (2003) Catheter design influences recurrence of catheter-related bloodstream infection in children with cancer. J Clin Oncol 21:3520–3525PubMedCrossRef Flynn PM, Willis B, Gaur AH, Shenep JL (2003) Catheter design influences recurrence of catheter-related bloodstream infection in children with cancer. J Clin Oncol 21:3520–3525PubMedCrossRef
9.
go back to reference Raad I, Kassar R, Ghannam D, Chaftari AM, Hachem R, Jiang Y (2009) Management of the catheter in documented catheter-related coagulase-negative staphylococcal bacteremia: remove or retain? Clin Infect Dis 49:1187–1194PubMedCrossRef Raad I, Kassar R, Ghannam D, Chaftari AM, Hachem R, Jiang Y (2009) Management of the catheter in documented catheter-related coagulase-negative staphylococcal bacteremia: remove or retain? Clin Infect Dis 49:1187–1194PubMedCrossRef
10.
go back to reference Donlan RM (2011) Biofilm elimination on intravascular catheters: important considerations for the infectious disease practitioner. Clin Infect Dis 52:1038–1045PubMedCrossRef Donlan RM (2011) Biofilm elimination on intravascular catheters: important considerations for the infectious disease practitioner. Clin Infect Dis 52:1038–1045PubMedCrossRef
11.
go back to reference Mermel LA, Allon M, Bouza E, Craven DE, Flynn P, O’Grady NP, Raad II, Rijnders BJ, Sherertz RJ, Warren DK (2009) Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 Update by the Infectious Diseases Society of America. Clin Infect Dis 49(1):1–45PubMedCrossRef Mermel LA, Allon M, Bouza E, Craven DE, Flynn P, O’Grady NP, Raad II, Rijnders BJ, Sherertz RJ, Warren DK (2009) Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 Update by the Infectious Diseases Society of America. Clin Infect Dis 49(1):1–45PubMedCrossRef
12.
go back to reference Del Pozo JL, Alonso M, Serrera A, Hernaez S, Aguinaga A, Leiva J (2009) Effectiveness of the antibiotic lock therapy for the treatment of port-related enterococci, Gram-negative, or Gram-positive bacilli bloodstream infections. Diagn Microbiol Infect Dis 63:208–212PubMedCrossRef Del Pozo JL, Alonso M, Serrera A, Hernaez S, Aguinaga A, Leiva J (2009) Effectiveness of the antibiotic lock therapy for the treatment of port-related enterococci, Gram-negative, or Gram-positive bacilli bloodstream infections. Diagn Microbiol Infect Dis 63:208–212PubMedCrossRef
13.
go back to reference Fernandez-Hidalgo N, Almirante B, Calleja R, Ruiz I, Planes AM, Rodriguez D, Pigrau C, Pahissa A (2006) Antibiotic-lock therapy for long-term intravascular catheter-related bacteraemia: results of an open, non-comparative study. J Antimicrob Chemother 57:1172–1180PubMedCrossRef Fernandez-Hidalgo N, Almirante B, Calleja R, Ruiz I, Planes AM, Rodriguez D, Pigrau C, Pahissa A (2006) Antibiotic-lock therapy for long-term intravascular catheter-related bacteraemia: results of an open, non-comparative study. J Antimicrob Chemother 57:1172–1180PubMedCrossRef
14.
go back to reference Messing B, Peitra-Cohen S, Debure A, Beliah M, Bernier JJ (1988) Antibiotic-lock technique: a new approach to optimal therapy for catheter-related sepsis in home-parenteral nutrition patients. JPEN J Parenter Enter Nutr 12:185–189CrossRef Messing B, Peitra-Cohen S, Debure A, Beliah M, Bernier JJ (1988) Antibiotic-lock technique: a new approach to optimal therapy for catheter-related sepsis in home-parenteral nutrition patients. JPEN J Parenter Enter Nutr 12:185–189CrossRef
15.
go back to reference Guedon C, Nouvellon M, Lalaude O, Lerebours E (2002) Efficacy of antibiotic-lock technique with teicoplanin in Staphylococcus epidermidis catheter-related sepsis during long-term parenteral nutrition. JPEN J Parenter Enter Nutr 26:109–113CrossRef Guedon C, Nouvellon M, Lalaude O, Lerebours E (2002) Efficacy of antibiotic-lock technique with teicoplanin in Staphylococcus epidermidis catheter-related sepsis during long-term parenteral nutrition. JPEN J Parenter Enter Nutr 26:109–113CrossRef
16.
go back to reference Giacometti A, Cirioni O, Ghiselli R, Orlando F, Mocchegiani F, Silvestri C, Licci A, De Fusco M, Provinciali M, Saba V, Scalise G (2005) Comparative efficacies of quinupristin–dalfopristin, linezolid, vancomycin, and ciprofloxacin in treatment, using the antibiotic-lock technique, of experimental catheter-related infection due to Staphylococcus aureus. Antimicrob Agents Chemother 49:4042–4045PubMedCrossRef Giacometti A, Cirioni O, Ghiselli R, Orlando F, Mocchegiani F, Silvestri C, Licci A, De Fusco M, Provinciali M, Saba V, Scalise G (2005) Comparative efficacies of quinupristin–dalfopristin, linezolid, vancomycin, and ciprofloxacin in treatment, using the antibiotic-lock technique, of experimental catheter-related infection due to Staphylococcus aureus. Antimicrob Agents Chemother 49:4042–4045PubMedCrossRef
17.
go back to reference Wiederhold NP, Coyle EA, Raad II, Prince RA, Lewis RE (2005) Antibacterial activity of linezolid and vancomycin in an in vitro pharmacodynamic model of gram-positive catheter-related bacteraemia. J Antimicrob Chemother 55:792–795PubMedCrossRef Wiederhold NP, Coyle EA, Raad II, Prince RA, Lewis RE (2005) Antibacterial activity of linezolid and vancomycin in an in vitro pharmacodynamic model of gram-positive catheter-related bacteraemia. J Antimicrob Chemother 55:792–795PubMedCrossRef
18.
go back to reference Lee JY, Ko KS, Peck KR, Oh WS, Song JH (2006) In vitro evaluation of the antibiotic lock technique (ALT) for the treatment of catheter-related infections caused by staphylococci. J Antimicrob Chemother 57(6):1110–1115PubMedCrossRef Lee JY, Ko KS, Peck KR, Oh WS, Song JH (2006) In vitro evaluation of the antibiotic lock technique (ALT) for the treatment of catheter-related infections caused by staphylococci. J Antimicrob Chemother 57(6):1110–1115PubMedCrossRef
19.
go back to reference Van Praagh AD, Li T, Zhang S, Arya A, Chen L, Zhang XX, Bertolami S, Mortin LI (2011) Daptomycin antibiotic lock therapy in a rat model of staphylococcal central venous catheter biofilm infections. Antimicrob Agents Chemother 55(9):4081–4089PubMedCrossRef Van Praagh AD, Li T, Zhang S, Arya A, Chen L, Zhang XX, Bertolami S, Mortin LI (2011) Daptomycin antibiotic lock therapy in a rat model of staphylococcal central venous catheter biofilm infections. Antimicrob Agents Chemother 55(9):4081–4089PubMedCrossRef
20.
go back to reference Rijnders BJ, Van Wijngaerden E, Vandecasteele SJ, Stas M, Peetermans WE (2005) Treatment of long-term intravascular catheter-related bacteraemia with antibiotic lock: randomized, placebo-controlled trial. J Antimicrob Chemother 55:90–94PubMedCrossRef Rijnders BJ, Van Wijngaerden E, Vandecasteele SJ, Stas M, Peetermans WE (2005) Treatment of long-term intravascular catheter-related bacteraemia with antibiotic lock: randomized, placebo-controlled trial. J Antimicrob Chemother 55:90–94PubMedCrossRef
21.
go back to reference Fortún J, Grill F, Martín-Dávila P, Blázquez J, Tato M, Sánchez-Corral J, García-San Miguel L, Moreno S (2006) Treatment of long-term intravascular catheter-related bacteraemia with antibiotic-lock therapy. J Antimicrob Chemother 58(4):816–821PubMedCrossRef Fortún J, Grill F, Martín-Dávila P, Blázquez J, Tato M, Sánchez-Corral J, García-San Miguel L, Moreno S (2006) Treatment of long-term intravascular catheter-related bacteraemia with antibiotic-lock therapy. J Antimicrob Chemother 58(4):816–821PubMedCrossRef
22.
go back to reference LaPlante KL, Mermel LA (2007) In vitro activity of daptomycin and vancomycin lock solutions on staphylococcal biofilms in a central venous catheter model. Nephrol Dial Transplant 22:2239–2246PubMedCrossRef LaPlante KL, Mermel LA (2007) In vitro activity of daptomycin and vancomycin lock solutions on staphylococcal biofilms in a central venous catheter model. Nephrol Dial Transplant 22:2239–2246PubMedCrossRef
23.
go back to reference Qu Y, Istivan TS, Daley AJ, Rouch DA, Deighton MA (2009) Comparison of various antimicrobial agents as catheter lock solutions: preference for ethanol in eradication of coagulase-negative staphylococcal biofilms. J Med Microbiol 58:442–450PubMedCrossRef Qu Y, Istivan TS, Daley AJ, Rouch DA, Deighton MA (2009) Comparison of various antimicrobial agents as catheter lock solutions: preference for ethanol in eradication of coagulase-negative staphylococcal biofilms. J Med Microbiol 58:442–450PubMedCrossRef
24.
go back to reference Stevens DL (2006) The role of vancomycin in the treatment paradigm. Clin Infect Dis 42(Suppl 1):S51–S57PubMedCrossRef Stevens DL (2006) The role of vancomycin in the treatment paradigm. Clin Infect Dis 42(Suppl 1):S51–S57PubMedCrossRef
25.
go back to reference Aumeran C, Thibert E, Chapelle FA, Hennequin C, Lesens O, Traoré O (2012) Assessment on experimental bacterial biofilms and in clinical practice of the efficacy of sampling solutions for microbiological testing of endoscopes. J Clin Microbiol 50:938–942PubMedCrossRef Aumeran C, Thibert E, Chapelle FA, Hennequin C, Lesens O, Traoré O (2012) Assessment on experimental bacterial biofilms and in clinical practice of the efficacy of sampling solutions for microbiological testing of endoscopes. J Clin Microbiol 50:938–942PubMedCrossRef
26.
go back to reference Pineau L, Roques C, Luc J, Michel G (1997) Automatic washer disinfector for flexible endoscopes: a new evaluation process. Endoscopy 29:372–379PubMedCrossRef Pineau L, Roques C, Luc J, Michel G (1997) Automatic washer disinfector for flexible endoscopes: a new evaluation process. Endoscopy 29:372–379PubMedCrossRef
27.
go back to reference Curtin J, Cormican M, Fleming G, Keelehan J, Colleran E (2003) Linezolid compared with eperezolid, vancomycin, and gentamicin in an in vitro model of antimicrobial lock therapy for Staphylococcus epidermidis central venous catheter-related biofilm infections. Antimicrob Agents Chemother 47(10):3145–3148PubMedCrossRef Curtin J, Cormican M, Fleming G, Keelehan J, Colleran E (2003) Linezolid compared with eperezolid, vancomycin, and gentamicin in an in vitro model of antimicrobial lock therapy for Staphylococcus epidermidis central venous catheter-related biofilm infections. Antimicrob Agents Chemother 47(10):3145–3148PubMedCrossRef
28.
go back to reference Chauhan A, Lebeaux D, Decante B, Kriegel I, Escande MC, Ghigo JM, Beloin C (2012) A rat model of central venous catheter to study establishment of long-term bacterial biofilm and related acute and chronic infections. PLoS One 7(5):e37281, Epub 2012 May 16PubMedCrossRef Chauhan A, Lebeaux D, Decante B, Kriegel I, Escande MC, Ghigo JM, Beloin C (2012) A rat model of central venous catheter to study establishment of long-term bacterial biofilm and related acute and chronic infections. PLoS One 7(5):e37281, Epub 2012 May 16PubMedCrossRef
29.
go back to reference Balestrino D, Souweine B, Charbonnel N, Lautrette A, Aumeran C, Traoré O, Forestier C (2009) Eradication of microorganisms embedded in biofilm by an ethanol-based catheter lock solution. Nephrol Dial Transplant 24:3204–3209PubMedCrossRef Balestrino D, Souweine B, Charbonnel N, Lautrette A, Aumeran C, Traoré O, Forestier C (2009) Eradication of microorganisms embedded in biofilm by an ethanol-based catheter lock solution. Nephrol Dial Transplant 24:3204–3209PubMedCrossRef
30.
go back to reference Chaieb K, Zmantar T, Souiden Y, Mahdouani K, Bakhrouf A (2011) XTT assay for evaluating the effect of alcohols, hydrogen peroxide and benzalkonium chloride on biofilm formation of Staphylococcus epidermidis. Microb Pathog 50:1–5PubMedCrossRef Chaieb K, Zmantar T, Souiden Y, Mahdouani K, Bakhrouf A (2011) XTT assay for evaluating the effect of alcohols, hydrogen peroxide and benzalkonium chloride on biofilm formation of Staphylococcus epidermidis. Microb Pathog 50:1–5PubMedCrossRef
31.
go back to reference Cazander G, van de Veerdonk MC, Vandenbroucke-Grauls CMJE, Schreurs MWJ, Jukema GN (2010) Maggot excretions inhibit biofilm formation on biomaterials. Clin Orthop Relat Res 468:2789–2796PubMedCrossRef Cazander G, van de Veerdonk MC, Vandenbroucke-Grauls CMJE, Schreurs MWJ, Jukema GN (2010) Maggot excretions inhibit biofilm formation on biomaterials. Clin Orthop Relat Res 468:2789–2796PubMedCrossRef
Metadata
Title
Activity of ethanol and daptomycin lock on biofilm generated by an in vitro dynamic model using real subcutaneous injection ports
Authors
C. Aumeran
P. Guyot
M. Boisnoir
C. Robin-Hennequin
M. Vidal
C. Forestier
O. Traore
O. Lesens
Clermont-Ferrand Biofilm Study Group
Publication date
01-02-2013
Publisher
Springer-Verlag
Published in
European Journal of Clinical Microbiology & Infectious Diseases / Issue 2/2013
Print ISSN: 0934-9723
Electronic ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-012-1732-5

Other articles of this Issue 2/2013

European Journal of Clinical Microbiology & Infectious Diseases 2/2013 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.